Health, Vaccines, Lyme Disease, FDA, Medicine.
would, therefore, slip by antibodies seeking OspA. Hence, researchers are testing the highest safe dose in clinical trials as they try to reduce the need for yearly booster shots. The goal is to deliver primary immunization over three doses and require a booster shot a year later that remains